Inflammatory myofibroblastic tumor: A demographic, clinical and therapeutic study of 92 cases | Zendy

Guoxiang Fu | Zendy; Chuchu Xu | Zendy; Nianfang Yao | Zendy; Jianzhong Gu | Zendy; Hanliang Jiang | Zendy; Xufeng Han | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Inflammatory myofibroblastic tumor: A demographic, clinical and therapeutic study of 92 cases

Author(s) -

Guoxiang Fu,

Chuchu Xu,

Nianfang Yao,

Jianzhong Gu,

Hanliang Jiang,

Xufeng Han

Publication year - 2019

Publication title -

mathematical biosciences and engineering

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.451

H-Index - 45

eISSN - 1551-0018

pISSN - 1547-1063

DOI - 10.3934/mbe.2019339

Subject(s) - medicine , radiation therapy , epidemiology , demographics , histopathology , adjuvant radiotherapy , head and neck , disease , soft tissue , oncology , pathology , surgery , demography , sociology

Inflammatory myofibroblastic tumors (IMT) was a rare kind of tumor defined by WHO since 2012. Little was known about this disease. There were controversies about IMT's behavior, predilection site, age distribution, and the best treatment methods. Here we provided a systematic overview on tumor demographical, clinical, biological features as well as treatment efficacy based on real cases from Surveillance, Epidemiology, and End Results (SEER) database.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research